Reiko Nakashima

Decreased Total and High Molecular Weight Adiponectin Are Independent Risk Factors for the Development of Type 2 Diabetes in Japanese-Americans

Reiko Nakashima, Nozomu Kamei, Kiminori Yamane et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 158 citations · Full text

Medicine, Biochemistry, Endocrinology +12

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Adeera Levin, Rajiv Agarwal, William G. Herrington et al. · Kidney International · 2020 · 118 citations · Full text

Medicine, Nephrology, Dialysis +16

Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus

Tomoko Tamura, Masayasu Yoneda, Kiminori Yamane et al. · Metabolism · 2007 · 64 citations

Medicine, Endocrinology, Orthopedic Surgery +14

Constitutive Overexpression of P-glycoprotein, Rather than Breast Cancer Resistance Protein or Organic Cation Transporter 1, Contributes to Acquisition of Imatinib-Resistance in K562 Cells

Chie Hirayama, Hiroshi Watanabe, Reiko Nakashima et al. · Pharmaceutical Research · 2007 · 52 citations

Medicine, Oncology, Pharmacology +14

Relationship between an effective dose of imatinib, body surface area, and trough drug levels in patients with chronic myeloid leukemia

Tatsuya Kawaguchi, Akinobu Hamada, Chie Hirayama et al. · International Journal of Hematology · 2009 · 47 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14